Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)

ClinicalTrials.gov ID: NCT06108219

Public ClinicalTrials.gov record NCT06108219. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 11:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Miricorilant in Adult Patients with Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)

Study identification

NCT ID
NCT06108219
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Corcept Therapeutics
Industry
Enrollment
175 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 25, 2023 (Actual)
Primary completion
Feb 13, 2026 (Actual)
Completion
Aug 24, 2026 (Actual)
Last update posted
Sep 29, 2026

2023 – 2026

United States locations

U.S. sites
48
U.S. states
16
U.S. cities
44
Facility City State ZIP Site status
Site #207 Chandler Arizona 85224 —
Site #209 Tucson Arizona 85712 —
Site #378 Huntington Park California 90255 —
Site #439 Lancaster California 93534 —
Site #469 Long Beach California 90815 —
Site #373 Los Angeles California 90056 —
Site #214 Panorama City California 91402 —
Site #233 Santa Ana California 92704 —
Site #452 Boca Raton Florida 33434 —
Site # 101 Gainesville Florida 32610 —
Site #465 Hallandale Florida 33009 —
Site #430 Hialeah Gardens Florida 33016 —
Site #458 Lakewood Rch Florida 38018 —
Site #475 Largo Florida 33777 —
Site #438 Miami Lakes Florida 33016 —
Site #460 Viera Florida 32940 —
Site #453 Houma Louisiana 70363 —
Site #451 Marrero Louisiana 70072 —
Site #061 Metairie Louisiana 70006 —
Site #440 Rockville Maryland 20854 —
Site #442 Saint Paul Minnesota 55114 —
Site #228 Kansas City Missouri 64131 —
Site #455 Jackson New Jersey 08724 —
Site #445 East Syracuse New York 13057 —
Site #454 New York New York 10033 —
Site #464 Morehead City North Carolina 29557 —
Site #447 Beavercreek Ohio 45440 —
Site #470 Columbus Ohio 43234 —
Site #448 Dayton Ohio 45145 —
Site #437 Westlake Ohio 44145 —
Site #461 Cordova Tennessee 38018 —
Site # 546 Arlington Texas 76012 —
Site #545 Austin Texas 78756 —
Site #211 Austin Texas 78757 —
Site #432 Brownsville Texas 78520 —
Site #370 Dallas Texas 75230 —
Site #213 Edinburg Texas 78539 —
Site #215 Edinburg Texas 78539 —
Site #431 Georgetown Texas 78626 —
Site # 066 Houston Texas 77030 —
Site #305 Houston Texas 77079 —
Site #459 Katy Texas 77494 —
Site #433 San Antonio Texas 78125 —
Site #212 San Antonio Texas 78229 —
Site #434 Waco Texas 78125 —
Site #441 West Jordan Utah 84088 —
Site #463 Manassas Virginia 20110 —
Site #226 Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 29 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06108219, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 29, 2026 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06108219 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →